India to Iceland: Dapagliflozin Export Trade Route
India has recorded 23 verified shipments of Dapagliflozin exported to Iceland, representing a combined trade value of $1.1M USD. This corridor is served by 1 active Indian exporters, with an average shipment value of $46.3K USD. The leading Indian exporter is WATSON PHARMA PRIVATE LIMITED, which accounts for 100% of total export value with 23 shipments worth $1.1M USD. On the buying side, JONAR TRANSPORT is the largest importer in Iceland with $1.1M USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Iceland Dapagliflozin corridor is one of India's established pharmaceutical export routes, with 23 shipments documented worth a combined $1.1M USD. The route is dominated by WATSON PHARMA PRIVATE LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's dapagliflozin manufacturing sector.
Across 1 active suppliers, the average shipment value stands at $46.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with dapagliflozin's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 20.5%, placing it at rank #15 among India's top dapagliflozin export destinations globally.
On the import side, key buyers of Indian dapagliflozin in Iceland include JONAR TRANSPORT. JONAR TRANSPORT is the single largest importer with 23 shipments valued at $1.1M USD.
